We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Regulatory News: The Annual General Meeting and Extraordinary General Meeting will be held at Medincell's (Paris:MEDCL) headquarters (3 rue des Frères Lumière, 34830 Jacou, France) on Thursday...
Article 223-16 du règlement Général de l’Autorité des Marchés Financiers Regulatory News: MedinCell (Paris:MEDCL): Place de cotation : Euronext Paris, Compartiment B Code ISIN : FR0004065605 Date...
Medincell (Paris:MEDCL): Olanzapine LAI (mdc-TJK) No PDSS* observed after completion of c.95% of the targeted injections for submission Full phase 3 safety results on track for H2 2024 Positive...
Olanzapine LAI (mdc-TJK) Aucun PDSS* observé après environ 95% des injections prévues pour une demande d’approbation Les données de sécurité complètes de la phase 3 sont attendues au S2 2024 Des...
Regulatory News: Medincell (Paris:MEDCL): The 2023-24 Universal Registration Document (URD) filed with the French market authority (Autorités des Marchés Financiers, or AMF) under the reference...
Regulatory News: Au titre du contrat de liquidité confié par la société MEDINCELL (Paris:MEDCL) à Kepler Cheuvreux, à la date du 30 juin 2024, les moyens suivants figuraient au compte de...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.8 | 4.62427745665 | 17.3 | 18.74 | 17.04 | 102561 | 17.94527197 | DE |
4 | 2.4 | 15.2866242038 | 15.7 | 18.74 | 14.04 | 78200 | 16.59688491 | DE |
12 | 1.74 | 10.6356968215 | 16.36 | 18.74 | 12.68 | 75920 | 15.25182379 | DE |
26 | 9.1 | 101.111111111 | 9 | 18.74 | 8.68 | 89389 | 13.69284915 | DE |
52 | 11.59 | 178.033794163 | 6.51 | 18.74 | 5.25 | 67340 | 11.42867597 | DE |
156 | 9.08 | 100.66518847 | 9.02 | 18.74 | 4.73 | 47487 | 9.36077372 | DE |
260 | 11.38 | 169.345238095 | 6.72 | 20 | 4.35 | 43265 | 9.88564611 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions